Abstract
Epstein-Barr virus (EBV), one of the eight known human herpesviruses, generally infects subclinically. However, in certain circumstances, EBV causes overt diseases such as infectious mononucleosis (IM), usually a selflimiting disorder, by its primary infection. Additionally, it associates the development of various human malignancies including EBV genome-positive Burkitts lymphoma (BL) and undifferentiated nasopharyngeal carcinoma (NPC). More recently, EBV infection has been thought to be etiologically linked to the occurrence of lymphoproliferative disease (LPD) in immunologically compromised individuals either with hereditary or secondary condition, and the other lifethreatening diseases such as hemophagocytic lymphohistiocytosis (HLH) and chronic active EBV infection (CAEBV). This review mainly introduces, focuses and discusses on the recent advances of EBV infection regarding its pathogenetic mechanism(s), diagnosis and treatment.
Keywords: Epstein-Barr virus, herpesviruses, human diseases
Current Pediatric Reviews
Title: Epstein-Barr Virus Infection and its Pathogenetic Roles for Human Diseases
Volume: 5 Issue: 4
Author(s): Motohiko Okano
Affiliation:
Keywords: Epstein-Barr virus, herpesviruses, human diseases
Abstract: Epstein-Barr virus (EBV), one of the eight known human herpesviruses, generally infects subclinically. However, in certain circumstances, EBV causes overt diseases such as infectious mononucleosis (IM), usually a selflimiting disorder, by its primary infection. Additionally, it associates the development of various human malignancies including EBV genome-positive Burkitts lymphoma (BL) and undifferentiated nasopharyngeal carcinoma (NPC). More recently, EBV infection has been thought to be etiologically linked to the occurrence of lymphoproliferative disease (LPD) in immunologically compromised individuals either with hereditary or secondary condition, and the other lifethreatening diseases such as hemophagocytic lymphohistiocytosis (HLH) and chronic active EBV infection (CAEBV). This review mainly introduces, focuses and discusses on the recent advances of EBV infection regarding its pathogenetic mechanism(s), diagnosis and treatment.
Export Options
About this article
Cite this article as:
Okano Motohiko, Epstein-Barr Virus Infection and its Pathogenetic Roles for Human Diseases, Current Pediatric Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339609791317324
DOI https://dx.doi.org/10.2174/157339609791317324 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Stem Cells-Clinical Implications for Cancer Therapy
Current Stem Cell Research & Therapy IP6 in Cancer Therapy: Past, Present and Future
Current Cancer Therapy Reviews Pharmacological and Clinical Studies on Purine Nucleoside Analogs- New Anticancer Agents
Mini-Reviews in Medicinal Chemistry Nanoparticles for Cancer Targeting: Current and Future Directions
Current Drug Delivery Molecular Mechanisms in Rheumatic Diseases: Rationale for Novel Drug Development – Introduction
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
Current Cancer Drug Targets Biological Activities of Yarrow Species (Achillea spp.)
Current Pharmaceutical Design The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations
Current Cancer Drug Targets Strategies for Retargeted Gene Delivery Using Vectors Derived from Lentiviruses
Current Gene Therapy Host Innate Immune Responses to Microbial Pathogens
Current Vascular Pharmacology Anti-Cancer Drugs of Today and Tomorrow: Are we Close to Making the Turn from Treating to Curing Cancer?
Current Pharmaceutical Design Natural Product Gossypol and its Derivatives in Precision Cancer Medicine
Current Medicinal Chemistry Respiratory Stem Cells and Progenitors: Overview, Derivation, Differentiation, Carcinogenesis, Regeneration and Therapeutic Application
Current Stem Cell Research & Therapy Drug Resistance in Childhood Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology The Role of DNA Repair Pathways in AML Chemosensitivity
Current Drug Targets Biologics in Systemic Sclerosis
Current Pharmaceutical Biotechnology Exploiting Protein Phosphatase Inhibitors Based on Cantharidin Analogues for Cancer Drug Discovery
Mini-Reviews in Medicinal Chemistry RAS/RAF/MEK Inhibitors in Oncology
Current Medicinal Chemistry Lifestyle Factors and MicroRNAs: A New Paradigm in Cancer Chemoprevention
MicroRNA Recent Advances in Targeted Anti-Vasculature Therapy: The Neuroblastoma Model
Current Drug Targets